GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medicalsystem Biotechnology Co Ltd (SZSE:300439) » Definitions » EV-to-EBITDA

Medicalsystem Biotechnology Co (SZSE:300439) EV-to-EBITDA : 8.86 (As of Jun. 19, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Medicalsystem Biotechnology Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medicalsystem Biotechnology Co's enterprise value is ¥2,789 Mil. Medicalsystem Biotechnology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥315 Mil. Therefore, Medicalsystem Biotechnology Co's EV-to-EBITDA for today is 8.86.

The historical rank and industry rank for Medicalsystem Biotechnology Co's EV-to-EBITDA or its related term are showing as below:

SZSE:300439' s EV-to-EBITDA Range Over the Past 10 Years
Min: -24.53   Med: 18.17   Max: 101.99
Current: 8.86

During the past 13 years, the highest EV-to-EBITDA of Medicalsystem Biotechnology Co was 101.99. The lowest was -24.53. And the median was 18.17.

SZSE:300439's EV-to-EBITDA is ranked better than
70.64% of 109 companies
in the Medical Diagnostics & Research industry
Industry Median: 15.16 vs SZSE:300439: 8.86

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-19), Medicalsystem Biotechnology Co's stock price is ¥9.41. Medicalsystem Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.691. Therefore, Medicalsystem Biotechnology Co's PE Ratio for today is 13.62.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Medicalsystem Biotechnology Co EV-to-EBITDA Historical Data

The historical data trend for Medicalsystem Biotechnology Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicalsystem Biotechnology Co EV-to-EBITDA Chart

Medicalsystem Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.59 12.09 17.91 9.14 7.49

Medicalsystem Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.27 13.96 14.58 7.49 9.12

Competitive Comparison of Medicalsystem Biotechnology Co's EV-to-EBITDA

For the Diagnostics & Research subindustry, Medicalsystem Biotechnology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicalsystem Biotechnology Co's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medicalsystem Biotechnology Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medicalsystem Biotechnology Co's EV-to-EBITDA falls into.



Medicalsystem Biotechnology Co EV-to-EBITDA Calculation

Medicalsystem Biotechnology Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2789.093/314.969
=8.86

Medicalsystem Biotechnology Co's current Enterprise Value is ¥2,789 Mil.
Medicalsystem Biotechnology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥315 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medicalsystem Biotechnology Co  (SZSE:300439) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Medicalsystem Biotechnology Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=9.41/0.691
=13.62

Medicalsystem Biotechnology Co's share price for today is ¥9.41.
Medicalsystem Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.691.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Medicalsystem Biotechnology Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medicalsystem Biotechnology Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicalsystem Biotechnology Co (SZSE:300439) Business Description

Traded in Other Exchanges
N/A
Address
No. 299 Qiming South Road, Yinzhou District, Zhejiang Province, Ningbo City, CHN, 315104
Medicalsystem Biotechnology Co Ltd is engaged in research and development, manufacture and distribution of diagnostic products. It provides in-vitro biochemical diagnostic reagents to healthcare facilities.
Executives
Zou Bing De Director
Xiong Hui Ping Secretary Dong
Zhuo Hong Ye Director
Wu Li Shan Supervisors
Fang Liang Executives
Zou Ji Hua Directors, executives
Wo Yan Bo Executives

Medicalsystem Biotechnology Co (SZSE:300439) Headlines

No Headlines